1,331
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Metastatic sites as predictors in advanced NSCLC treated with PD-1 inhibitors: a systematic review and meta-analysis

, , , , , & show all
Pages 1278-1287 | Received 06 Jul 2020, Accepted 10 Sep 2020, Published online: 20 Oct 2020

Figures & data

Figure 1. A flowchart of literature screening method

Figure 1. A flowchart of literature screening method

Table 1. The characteristics of included studies

Table 2. The reported metastatic sites of advanced NSCLC in different studies

Figure 2. Forest plot of the impact of different metastatic sites on overall survival following PD-1 therapy

Figure 2. Forest plot of the impact of different metastatic sites on overall survival following PD-1 therapy

Figure 3. Forest plot of the impact of different metastatic sites on progression-free survival following PD-1 therapy

Figure 3. Forest plot of the impact of different metastatic sites on progression-free survival following PD-1 therapy

Figure 4. Forest plot of the impact of the number of metastatic sites on survival outcome following PD-1 therapy

Figure 4. Forest plot of the impact of the number of metastatic sites on survival outcome following PD-1 therapy

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.